Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$636K Sell
8,280
-1,805
-18% -$130K 0.21% 93
2021
Q4
$772K Buy
10,085
+45
+0.4% +$3.31K 0.25% 83
2021
Q3
$741K Buy
+10,040
New +$753K 0.27% 87
2021
Q2
Sell
-3,300
Closed -$245K 144
2021
Q1
$245K Buy
+3,300
New +$251K 0.09% 126

Other funds holding HOLX

Legacy Capital Partners's HOLX Position: Q1 2022 in Review

Legacy Capital Partners reduced its Hologic (HOLX) stake by 18% in Q1 2022, selling an estimated $130K and leaving 8,280 shares worth $636K. The position accounts for 0.21% of the portfolio, ranked #93.

Legacy Capital Partners first reported a position in HOLX in Q1 2021 and has held it in 4 quarters since. The position peaked at $772K in Q4 2021. 699 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

  • Legacy Capital Partners held 8,280 shares of Hologic worth $636K as of Q1 2022.
  • Legacy Capital Partners sold 1,805 Hologic shares in Q1 2022, an estimated $130K.
  • Hologic made up 0.21% of Legacy Capital Partners's portfolio in Q1 2022, its #93 holding.
  • Legacy Capital Partners first reported a position in Hologic in Q1 2021 and has held it in 4 quarters since.
  • Legacy Capital Partners's Hologic position peaked at $772K in Q4 2021.
  • 699 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.